MELISSA GLEASON: Open Payments
NPI 1538341805 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 22 payments from 11 companies in 2025. Trend: 2023 $366 · 2024 $366 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $178 |
| Pacira Pharmaceuticals Incorporated | 3 | $82 |
| Kerecis Limited | 1 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| Exeltis, USA Inc. | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| Organon LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Hologic Sales and Service, LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: Veozah, Exparel, Kerecis SurgiClose, SLYND, ACCRUFER, NEXPLANON, Cologuard Collection Kit, APTIMA.
Industry payments across AL — which companies pay providers there.
